Skip to main content
. 2012 May 24;7(8):1310–1319. doi: 10.2215/CJN.00260112

Figure 3.

Figure 3.

The proportion of patient with non-DSA anti-HLA antibodies is not significantly different in both groups. (A) Proportions of patients with no donor-specific antibodies (DSAs) anti–human leukocyte antigens (anti-HLAs) antibodies either with or without allograft nephrectomy. (B) Proportions of patients with no DSAs anti-HLA class I antibodies with or without allograft nephrectomy. (C) Proportions of patients with no DSAs anti-HLA class II antibodies with or without allograft nephrectomy. GL, graft loss; GN, graft nephrectomy.